Every marker on the LONVE panel was chosen because it independently predicts healthspan, disease risk, or recovery capacity. Here's what each one tells us.

Three-month average glycemia. Independently predicts cardiovascular and all-cause mortality.
Screen for impaired fasting glucose; consistent values >100 mg/dL indicate prediabetes.
Earliest detectable marker of insulin resistance — often elevated years before glucose changes.
Calculated insulin-resistance index (glucose × insulin / 405).
Counts every atherogenic lipoprotein particle. Superior to LDL-C for cardiovascular risk (AHA 2023).
Genetic, lifelong cardiovascular risk factor. Should be measured at least once in every adult.
Conventional atherogenic cholesterol — interpret alongside ApoB.
Reverse cholesterol transport capacity. Very high HDL is not always protective.
Fasting triglycerides correlate with insulin resistance and VLDL load.
Surrogate for insulin sensitivity and small-dense LDL burden.
High-sensitivity C-reactive protein. JUPITER and CANTOS data link it to MACE risk.
Reflects methylation status; elevated levels associate with vascular and cognitive decline.
Sensitive marker of hepatic oxidative stress, often elevated in metabolic syndrome.
Drives endothelial dysfunction at the high end; very low values may reflect malnutrition.
Endocrine Society 2018 guidelines define hypogonadism <264 ng/dL on two morning draws.
Bioavailable androgen — the fraction not bound to SHBG or albumin.
Critical for male bone, brain, and cardiometabolic health. Suppression is harmful.
Phase-dependent. Postmenopausal optimization is individualized per NAMS guidelines.
Mid-luteal progesterone confirms ovulation and supports sleep and mood.
Pituitary signal; >25 mIU/mL with amenorrhea suggests menopausal transition.
Modulates bioavailable sex hormones. Low SHBG correlates with insulin resistance.
Adrenal androgen reserve; declines ~2%/year after age 30.
Drawn between 7–9 AM. Diurnal salivary curves give a fuller picture of HPA-axis function.
Downstream marker of GH axis activity. Optimal range varies by age; very high values associate with cancer risk.
Most sensitive screening test. Functional medicine targets 1–2 mIU/L.
Active hormone — interpret with reverse T3 for full picture.
Storage hormone, converted to T3 peripherally.
Positive titer suggests Hashimoto autoimmunity even with normal TSH.
Endocrine Society defines deficiency <20, insufficiency 20–29 ng/mL.
Symptoms of deficiency appear well within the lab 'normal' range; pair with MMA.
Better tissue index than serum folate.
Intracellular magnesium — more sensitive than serum.
Erythrocyte EPA+DHA content. <4% associates with sudden cardiac death.
Required for testosterone synthesis, immune function, wound healing.
Acute-phase reactant — high values can reflect inflammation, not iron overload.
Screens for hemochromatosis and iron deficiency together with ferritin.